Faced with the omicron variant of COVID, feds have paused shipments of two monoclonal antibody treatments - while waiting on more doses of the one brand still proving to be effective.
Faced with the omicron variant of COVID, feds have paused shipments of two monoclonal antibody treatments - while waiting on more doses of the one brand still proving to be effective.
Faced with the omicron variant of COVID, feds have paused shipments of two monoclonal antibody treatments - while waiting on more doses of the one brand still proving to be effective.